|
GB2434312B
(en)
|
2006-01-18 |
2011-06-29 |
Gw Pharma Ltd |
Cannabinoid-containing plant extracts as neuroprotective agents
|
|
GB2450753B
(en)
*
|
2007-07-06 |
2012-07-18 |
Gw Pharma Ltd |
New Pharmaceutical formulation
|
|
GB2451254A
(en)
*
|
2007-07-24 |
2009-01-28 |
Gw Pharma Ltd |
Cannabidiol for use in the treatment of neurodegenerative conditions
|
|
US20110257256A1
(en)
*
|
2008-07-31 |
2011-10-20 |
Bionoria Research Gmbh |
Cannabinoids for use in treating or preventing cognitive impairment and dementia
|
|
GB2471523A
(en)
|
2009-07-03 |
2011-01-05 |
Gw Pharma Ltd |
Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
|
|
GB2478595B
(en)
*
|
2010-03-12 |
2018-04-04 |
Gw Pharma Ltd |
Phytocannabinoids in the treatment of glioma
|
|
GB2479153B
(en)
*
|
2010-03-30 |
2014-03-19 |
Gw Pharma Ltd |
The phytocannabinoid cannabidivarin (CBDV) for use in the treatment of epilepsy
|
|
TWI583374B
(zh)
|
2010-03-30 |
2017-05-21 |
Ｇｗ伐瑪有限公司 |
使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
|
|
GB2487183B
(en)
*
|
2011-01-04 |
2018-10-03 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy
|
|
US8445034B1
(en)
|
2010-11-02 |
2013-05-21 |
Albert L Coles, Jr. |
Systems and methods for producing organic cannabis tincture
|
|
GB2487712B
(en)
|
2011-01-04 |
2015-10-28 |
Otsuka Pharma Co Ltd |
Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
|
|
GB201111261D0
(en)
|
2011-07-01 |
2011-08-17 |
Gw Pharma Ltd |
Cannabinoids for use in the treatment of neuro-degenerative diseases or disorders
|
|
GB2514054A
(en)
|
2011-09-29 |
2014-11-12 |
Gw Pharma Ltd |
A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
|
|
GB2504263B
(en)
|
2012-06-08 |
2015-09-16 |
Gw Pharma Ltd |
Synergistic therapies for neuroprotection
|
|
CA2895805A1
(en)
|
2012-12-18 |
2014-06-26 |
Kotzker Consulting Llc |
Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
|
|
CA3012383C
(en)
|
2013-02-28 |
2021-03-02 |
Teewinot Technologies Limited |
Biosynthesis of cannabinoids
|
|
EP2968259B1
(en)
*
|
2013-03-14 |
2022-09-14 |
SC Laboratories Inc. |
Bioactive concentrates and uses thereof
|
|
US10774288B2
(en)
|
2013-09-18 |
2020-09-15 |
The Werc Shop, LLC |
Terpene-based compositions, processes, methodologies for creation and products thereby
|
|
US9220294B2
(en)
|
2014-02-11 |
2015-12-29 |
Timothy McCullough |
Methods and devices using cannabis vapors
|
|
US10821240B2
(en)
|
2014-02-11 |
2020-11-03 |
Vapor Cartridge Technology Llc |
Methods and drug delivery devices using cannabis
|
|
US9380813B2
(en)
|
2014-02-11 |
2016-07-05 |
Timothy McCullough |
Drug delivery system and method
|
|
GB2530001B
(en)
|
2014-06-17 |
2019-01-16 |
Gw Pharma Ltd |
Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
|
|
GB2527599A
(en)
|
2014-06-27 |
2015-12-30 |
Gw Pharma Ltd |
Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
|
|
CA2990071C
(en)
|
2014-07-14 |
2023-01-24 |
Librede Inc. |
Production of cannabigerolic acid
|
|
US11293038B2
(en)
|
2014-07-14 |
2022-04-05 |
Librede Inc. |
Production of cannabinoids in yeast
|
|
CN109593651A
(zh)
|
2014-08-25 |
2019-04-09 |
蒂威诺特科技有限公司 |
用于大麻素化合物的同时生产的设备和方法
|
|
GB2531278A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531281A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabidiol in the treatment of intractable epilepsy
|
|
GB2531282A
(en)
|
2014-10-14 |
2016-04-20 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
BR122021018502B1
(pt)
|
2014-10-21 |
2022-05-03 |
United Cannabis Corp |
Formulação de canabinoide líquida
|
|
GB2539472A
(en)
|
2015-06-17 |
2016-12-21 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US9585867B2
(en)
|
2015-08-06 |
2017-03-07 |
Charles Everett Ankner |
Cannabinod formulation for the sedation of a human or animal
|
|
GB2541191A
(en)
|
2015-08-10 |
2017-02-15 |
Gw Pharma Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
AU2016337507B2
(en)
*
|
2015-10-16 |
2019-09-19 |
Impact Biosciences Corp. |
Methods and compositions for treating traumatic brain injury
|
|
EP3383387B1
(en)
*
|
2015-12-05 |
2025-11-05 |
Canna-B Cure Ltd |
Veterinary composition comprising cbd and/or thc for use in the treatment of stress in bees
|
|
US11172698B1
(en)
|
2016-02-08 |
2021-11-16 |
Jeff Nordahl |
Pasteurized juice formed from raw cannabis
|
|
US11191794B1
(en)
|
2016-02-08 |
2021-12-07 |
Jeff Nordahl |
Packaged hemp products formed from raw cannabis
|
|
US9956174B1
(en)
|
2016-02-08 |
2018-05-01 |
Jeff Nordahl |
Packaged frozen cubes of cannabis juice purée with added decarboxylated cannabis material
|
|
US11779622B1
(en)
|
2016-02-08 |
2023-10-10 |
Jeff Nordahl |
Packaged raw cannabis powder
|
|
PT3429580T
(pt)
*
|
2016-03-16 |
2025-08-12 |
Buzzelet Development And Technologies Ltd |
Composição de canabinoides enriquecida em terpenos
|
|
GB2548873B
(en)
|
2016-03-31 |
2020-12-02 |
Gw Res Ltd |
Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
|
|
GB2549278B
(en)
*
|
2016-04-11 |
2021-02-17 |
Gw Res Ltd |
Use of cannabidivarin in the treatment of autism spectrum disorder
|
|
GB2549277B
(en)
|
2016-04-11 |
2021-02-17 |
Gw Res Ltd |
Cannabidiolic Acid for use in the Treatment of Autism Spectrum Disorder
|
|
US10499584B2
(en)
|
2016-05-27 |
2019-12-10 |
New West Genetics |
Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
|
|
US9717683B1
(en)
|
2016-06-29 |
2017-08-01 |
Ep Pharma, Llc |
Low-temperature inhalation administration of cannabinoid entities
|
|
WO2018000094A1
(en)
|
2016-06-29 |
2018-01-04 |
CannScience Innovations Inc. |
Decarboxylated cannabis resins, uses thereof and methods of making same
|
|
GB2551987A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2551986A
(en)
|
2016-07-01 |
2018-01-10 |
Gw Res Ltd |
Parenteral formulations
|
|
GB2553139A
(en)
|
2016-08-25 |
2018-02-28 |
Gw Res Ltd |
Use of cannabinoids in the treatment of multiple myeloma
|
|
CA3077624A1
(en)
*
|
2016-10-01 |
2018-04-05 |
James Smeeding |
Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof
|
|
CN109963595B
(zh)
*
|
2016-10-11 |
2023-02-03 |
Gbs全球生物制药公司 |
用于治疗神经退行性疾病的含有大麻素的复合混合物
|
|
US10239808B1
(en)
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
GB2557921A
(en)
|
2016-12-16 |
2018-07-04 |
Gw Res Ltd |
Use of cannabinoids in the treatment of angelman syndrome
|
|
US10857107B2
(en)
|
2017-02-01 |
2020-12-08 |
Gbs Global Biopharma, Inc. |
Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders
|
|
US20190374502A1
(en)
*
|
2017-02-09 |
2019-12-12 |
Bodhi Research & Development Inc. |
Cannabinoid-Containing Fatty Acid Formulations for Treating Disorders of the Nervous System
|
|
GB2559774B
(en)
|
2017-02-17 |
2021-09-29 |
Gw Res Ltd |
Oral cannabinoid formulations
|
|
GB2560019A
(en)
|
2017-02-27 |
2018-08-29 |
Gw Res Ltd |
Use of cannabinoids in the treatment of leukaemia
|
|
BR112019019966A2
(pt)
|
2017-03-24 |
2020-04-28 |
Trait Biosciences Inc |
biossíntese in vivo de alto nível e isolamento de canabinoides solúveis em água em sistemas de plantas
|
|
CN107137605A
(zh)
*
|
2017-03-27 |
2017-09-08 |
昭通天麻产业开发有限公司 |
一种由乌天麻提取物和植物大麻提取物及口服载体组成的组合物
|
|
WO2018205038A1
(en)
*
|
2017-05-12 |
2018-11-15 |
Tetra Bio-Pharma Inc. |
Compositions comprising cannabinoids and terpenes useful in the treatment of cancer and vascular ocular disorders via inhibition of hedgehog signalling
|
|
GB2564383B
(en)
|
2017-06-23 |
2021-04-21 |
Gw Res Ltd |
Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
|
|
US11905543B2
(en)
|
2017-07-11 |
2024-02-20 |
Trait Biosceinces, Inc. |
In vivo generation of water-soluble acetylated cannabinoid glycoside compounds in plant cell suspension cultures
|
|
CN111465700A
(zh)
|
2017-07-11 |
2020-07-28 |
特征生物科学公司 |
在酵母和植物细胞悬浮培养物中产生水溶性大麻素化合物和材料组合物
|
|
US11946059B2
(en)
|
2017-07-11 |
2024-04-02 |
Trait Biosciences, Inc. |
In vivo generation of water-soluble cannabinoids in plant cell suspension cultures
|
|
GB2564459B
(en)
|
2017-07-12 |
2022-03-09 |
Gw Res Ltd |
Use of cannabinoids in the treatment of a neurodegenerative disease or disorder
|
|
US10272360B2
(en)
|
2017-08-05 |
2019-04-30 |
Priya Naturals, Inc. |
Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
|
|
EP3687527A4
(en)
*
|
2017-09-25 |
2021-05-26 |
Canopy Health Innovations |
COMPOSITIONS OF CANNABIDIOL, TETRAHYDROCANNABINOL, TERPENS AND FLAVONOIDS AND THEIR USES FOR TREATMENT OF INSOMNIA
|
|
US10307392B2
(en)
*
|
2017-10-21 |
2019-06-04 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
US20190183849A1
(en)
*
|
2017-10-21 |
2019-06-20 |
Alexander Kariman |
Compound and method for treatment of diseases and disorders
|
|
GB2568929A
(en)
|
2017-12-01 |
2019-06-05 |
Gw Res Ltd |
Use of cannabinoids in the treatment of epilepsy
|
|
US10722545B2
(en)
|
2018-01-01 |
2020-07-28 |
Alexander Kariman |
Compound and method for treatment of movement disorders
|
|
GB2569961B
(en)
|
2018-01-03 |
2021-12-22 |
Gw Res Ltd |
Pharmaceutical
|
|
CA3089994A1
(en)
|
2018-01-31 |
2019-08-08 |
Canopy Holdings, LLC |
Hemp powder
|
|
EP3773527A4
(en)
*
|
2018-03-30 |
2022-04-13 |
India Globalization Capital, Inc. |
METHOD AND COMPOSITION FOR THE TREATMENT OF CNS DISEASES
|
|
GB201806953D0
(en)
|
2018-04-27 |
2018-06-13 |
Gw Res Ltd |
Cannabidiol Preparations
|
|
US20200035118A1
(en)
|
2018-07-27 |
2020-01-30 |
Joseph Pandolfino |
Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
|
|
US20220304963A1
(en)
*
|
2018-07-27 |
2022-09-29 |
Basil Shaaban |
Composition having an optimized fatty acid excipient profile
|
|
US10897925B2
(en)
|
2018-07-27 |
2021-01-26 |
Joseph Pandolfino |
Articles and formulations for smoking products and vaporizers
|
|
WO2020077153A1
(en)
|
2018-10-10 |
2020-04-16 |
Canopy Holdings, LLC |
Synthesis of cannabigerol
|
|
BR112021009021A2
(pt)
*
|
2018-11-09 |
2021-10-26 |
Agriculture Victoria Services Pty Ltd |
Plantas de cannabis com um perfil canabinoide enriquecido de canabidiol e delta-9-tetra-hidrocanabinol
|
|
CA3061143A1
(en)
*
|
2018-11-09 |
2020-05-09 |
Cronos Group Inc. |
Liquid composition for an electronic vapor device
|
|
US12220396B2
(en)
|
2019-05-03 |
2025-02-11 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
ES2986503T3
(es)
|
2019-05-03 |
2024-11-11 |
Zyus Life Sciences Inc |
Formulación para el manejo del dolor que comprende tetrahidrocannabinol (THC), cannabicromeno (CBC) y cannabidiol (CBD) en una proporción determinada
|
|
US12178797B2
(en)
|
2019-05-03 |
2024-12-31 |
Zyus Life Sciences Inc. |
Formulation for pain management
|
|
GB2584341B
(en)
|
2019-05-31 |
2023-03-01 |
Gw Res Ltd |
Cannabinoid formulations
|
|
US12557843B2
(en)
*
|
2019-07-15 |
2026-02-24 |
Raymond Louis Larson |
Other than cannabinoids, flavonoids, and terpenes
|
|
CA3154135A1
(en)
|
2019-09-16 |
2021-03-25 |
Vapor Cartridge Technology Llc |
Drug delivery system with stackable substrates
|
|
US12409131B2
(en)
|
2019-10-03 |
2025-09-09 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
AU2020358869A1
(en)
|
2019-10-03 |
2022-04-14 |
Pike Therapeutics Usa, Inc. |
Transdermal delivery of dronabinol
|
|
US12016829B2
(en)
|
2019-10-11 |
2024-06-25 |
Pike Therapeutics Inc. |
Pharmaceutical composition and method for treating seizure disorders
|
|
EP4041209A4
(en)
|
2019-10-11 |
2024-01-24 |
Pike Therapeutics, Inc. |
TRANSDERMAL COMPOSITIONS COMPRISING CANNABIDIOL (CBD) FOR USE IN THE TREATMENT OF EPILEPTIC DISORDERS
|
|
US12268699B2
(en)
|
2019-10-14 |
2025-04-08 |
Pike Therapeutics Inc. |
Transdermal delivery of tetrahydrocannabinol
|
|
US12121617B2
(en)
|
2019-10-14 |
2024-10-22 |
Pike Therapeutics Inc. |
Transdermal delivery of cannabidiol
|
|
CA3155181A1
(en)
|
2019-10-14 |
2021-04-22 |
Pike Therapeutics, Inc., 1219014 B.C. Ltd. |
Transdermal delivery of cannabidiol
|
|
GB202002754D0
(en)
|
2020-02-27 |
2020-04-15 |
Gw Res Ltd |
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
|
|
CN115551592A
(zh)
*
|
2020-03-17 |
2022-12-30 |
陶里加科学股份有限公司 |
药用大麻素组合物、制造方法和治疗方法
|
|
US11160757B1
(en)
|
2020-10-12 |
2021-11-02 |
GW Research Limited |
pH dependent release coated microparticle cannabinoid formulations
|
|
KR20220084761A
(ko)
|
2020-12-14 |
2022-06-21 |
강원대학교산학협력단 |
헴프 껍질 추출물을 포함하는 인지기능 개선용 조성물
|
|
CN113368086B
(zh)
*
|
2021-08-11 |
2021-12-03 |
龙麻(上海)医药研发有限责任公司 |
一种大麻素组合物及其在制备治疗帕金森、阿尔茨海默等神经退行性疾病的药物中的应用
|
|
US12036228B2
(en)
|
2022-04-12 |
2024-07-16 |
Shackelford Pharma Inc. |
Treatment of seizure disorders
|
|
AU2023321655A1
(en)
|
2022-08-12 |
2025-02-13 |
Jazz Pharmaceuticals Research Uk Limited |
Oral solid dosage forms comprising cannabinoids
|
|
WO2024148117A2
(en)
*
|
2023-01-04 |
2024-07-11 |
Florascience Inc. |
Methods of treating neurodegenerative diseases or conditions
|
|
WO2025090587A1
(en)
|
2023-10-23 |
2025-05-01 |
Inmed Pharmaceuticals Inc. |
Cannabinoids compounds and their use in the treatment of neuronal disorders
|
|
WO2025172553A1
(en)
|
2024-02-14 |
2025-08-21 |
Jazz Pharmaceuticals Research Uk Limited |
Oral solid dosage forms comprising cannabinoids
|
|
WO2025234537A1
(ko)
*
|
2024-05-07 |
2025-11-13 |
주식회사 퓨처에프바이오텍 |
대마 종자 발효물을 포함하는 비만 또는 인지기능 개선용 조성물
|